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Abstract: A single pulse of N-ethyl-N-nitrosourea (ENU), applied to BDIX rats 
during the perinatal age, specifically results in a high incidence of neuroectodermal 
neoplasms in the central and peripheral nervous system (NS). The pronounced 
sensitivity of the developing NS suggests a dependence of the carcinogenic effect 
on the proliferative and/or differentiative state of the target cells at the time of the 
ENU pulse. The specificity of ENU for the NS cannot be due to tissue variations in 
the degree of carcinogen-cell interactions, since the reactive, electrophilic ethyl 
cation is produced by rapid, nonenzymatic decomposition of ENU indiscriminately 
in all tissues. Correspondingly, the initial molar fractions of ethylated purine bases 
are similar in the DNA of "high-risk" (perinatal brain) and "low-risk" tissues (e.g., 
liver; adult brain). However, while the respective half lives in DNA of N7-ethyl-
guanine and N3-ethyladenine show only minor differences for both types of tissues, 
the mutagenic ethylation product 06-ethylguanine is removed from brain DNA 
very much more slowly than from the DNA of other tissues. Together with their 
high rate of DNA replication during the perinatal age, the incapacity of rat brain 
cells for enzymatic elimination of 06-alkylguanine from their DNA could account 
for an increased probability of neoplastic conversion, and hence for the NS speci-
ficity of ENU in the rat. 
Dissociated fetal (18th day of gestation) BDIX-rat brain cells (FBC), trans-
ferred to long-term cell culture at 20-90 hr after a transplacental pulse of ENU 
(75 p.g/g body weight), contrary to untreated FBC became tumorigenic after ca. 
200 days (as assayed by reimplantation into baby BDIX rats). The multic10nal 
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proliferation of neoplastic neurogenic cells was preceded by a characteristic sequence 
of phenotypic alterations of the cultured FBC. This "in vivo-in vitro system" may 
represent a model for analysis of the unclarified interval between primary carci-
nogen-cell interaction and the onset of malignant growth on the one hand, and for 
characterization of the type and differentiated state of the particular FBC that 
undergo neoplastic transformation by ENU on the other. 
One of the few signposts in the present labyrinth of approaches to the problem 
of carcinogenesis remains the notion that direct interactions of carcinogenic chemi-
cals with informational macromolecules, and with genetic material in particular, 
can apparently be necessary prerequisites for initiation of the process of neoplastic 
transformation (1-3). There is evidence indicating a mostly covalent binding to 
DNA of many carcinogens, or rather of their reactive, generally electrophilic 
metabolic derivatives ("ultimate carcinogens") (1,2). Furthermore, most carcinogens 
prove to be mutagenic when tested in appropriate microbial and eukaryote systems 
(4). Extensive analyses, however, of both the metabolic activation of oncogenic 
agents (5) as well as the physicochemical nature of their primary interactions 
with various cellular constituents (2,3) have thus far failed to provide unequivocal 
correlations between the extent and types of initial reactions on the one hand, and 
the carcinogenic effect on the other. 
Until recently, surprisingly little attention has been given to the question 
whether specific phenotypic properties of cells coming into play after the initial 
carcinogen-cell interaction might perhaps have an equally important influence on 
the probability of neoplastic transformation. Of particular relevance in this context 
may be the rate of target cell proliferation, since repeated rounds of DNA replica-
tion and cell division seem to be required for the "fixation" and phenotypic ex-
pression of carcinogen-induced genome alterations (3, 6-10) and the capacity of 
target cells to eliminate and correctly replace (repair) carcinogen-modified, poten-
tially mutagenic molecular structures in their DNA (11-20). This would shift the 
emphasis towards the differentiative state and functional behavior of target cells 
and, accordingly, require characterization of possibly small subpopulations of 
"high-risk cells" contained in the target tissues with their generally complex cellular 
composition. A lead in this direction may be provided by the pronounced tissue 
specificity of the tumorigenic effect of certain chemical carcinogens in those cases 
where this specificity is not a "secondary" one, i.e., not due to tissue differences 
in the activity of enzymes required for the formation of their ultimate reactive forms 
(18, 19). 
Nervous System (NS)-specific Carcinogenic Effect oj ENU in the Rat 
A "mo~el carcinogen" that fulfils the above condition is the ethylating agent 
N-ethyl-N-mtrosourea (ENU) (21). Alkylation of nucleic acid constituents in rela-
tion to mutagen~sis ~nd carcinogenesis has recently received much attention (2-5, 
22, 23). Under m VIVO conditions, ENU decomposes heterolytically (i.e., without 
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FIG. I. Mortality with neuroectodermal tumors in the offspring of BDIX rats treated with 
a single, transplacental intraperitoneal (i.p.) injection of either 25 or 75 mg ofENU/kg body 
wt., on the 18th day of gestation. Each point represents one animal. Note normal distribution 
of times until death with tumors. Horizontal lines (probits) indicate I standard deviation of 
the Tao values, respectively (probability grid). r represents the percentage of animals with mac-
roscopically detectable neoplasms (27). A: ENU, 25 mg/kg ; Tso, 240 days± 19% (S.D.); r, 
89%. B: ENU, 75 mg/kg; Tso, 195 days±8% (S.D.); r, 89%. The corresponding values 
for BDIX rats treated with a single i.p. injection of 75 mg of ENU/kg body wt. at the age of 
10 days, were Tso=291 days±22% (S.D.), and r=95%, respectively (18, 19). 
enzyme involvement) with a half life of tl / 2 ;:-;;S min (24). The ultimate reactant, 
an electrophilic ethyl cation, is thus produced indiscriminately in all tissues. In spite 
of this fact, a single pulse of ENU, when applied to rats during the perinatal age, 
specifically results in a very high incidence of neuroectodermal neoplasms in the 
central and peripheral NS (21, 25, 26), after a dose-dependent "latency period" 
(Fig. 1) (18, 19, 27). The panel of ENU-induced rat tumors encompasses mixed 
glioma-, astrocytoma-, oligodendroglioma-, glioblastoma-, and ependymoma-like 
neoplasms in the brain; and neurinoma- or Schwannoma-like tumors in the periph-
eral NS (21, 26, 27). The particular sensitivity of the developing NS suggests 
that the carcinogenic effect may be related to the proliferative and/or differentiative 
state of the target cells at the time of the ENU pulse (18, 19). In the rat NS, 
the perinatal age is characterized by the presence of highly proliferative matrices, 
particularly in the sub ependymal area of the brain (Fig. 2) (18, 19,28,29). 
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FIG . 2. High DNA-synthetic activity in the subependymal proliferative matrix of the feta l 
( 18th day of gestation) BDIX·rat brain. Feulgen-stained sagi ttal section. Autoradiogram 
(llford K5 enulsion ; e""posure time, 15 days) prepared after a transplacen tal pulse of 
thymidine.methyi-3H (spec. act., IS Ci/mmole; 3 p Ci!g body wt. ). 3H-Iabe1ed, D A-
synthesizing nuclei: black spots (19). 
Molecular Mechanisms 
1. Initial degree of DNA ethylation by ENU 
As a result of their equal exposure to the ENU-derived ethyl cation, the initial 
(at 1 hr after the ENU pulse) extent of base ethylation in the DNA of both "high-
risk" and " low-risk" tissues could be expected to be of similar magnitude. To test 
this assumption, [l-14C]-ENU (specific activity, 5.72 CiJmole; Farbwerke Hoechst 
AG, FrankfurtJMain, Germany) was applied to fetal (18th day of gestation), 10-
day-old, and adult rats of the BDIX strain (30) in vivo, and DNA was then isolated 
from brain, liver, and other pooled tissues with a modified Kirby method (24). 
After mild hydrolysis of DNA in 0.1 N HCI at 37°C for 20 hr (31), and addition of 
nonradioactive ethylated purine bases as "markers," radiochromatography was 
performed on Sephadex G-IO (Fig. 3), with 0.05 M ammonium formate buffer, pH 
6.8 (32). The molar fractions of the ethylated bases were calculated from the 
integral HC-activity of the corresponding chromatographic peaks, considering their 
specific HC-activity as identical with that of the [l-14C]-ENU applied. The amounts 
of guanine (G) and adenine (A) were derived from the UV-extinction coefficients, 
at neutral pH, of .0260 = 7,200 for G, and 0:260= 13,300 for A (33). 
The initial (1 hr after injection of 75 pg of [l-HC]-ENU Jg) molar fractions of 
N7-ethylguanine (N7_EtGJG), 0 6-ethylguanine (06-EtGJG) and N3-ethyladenine 
(N3-EtAJA) in the DNA of "high risk" (fetal and lO-day-old brain) and "low risk" 
(e.g., liver; adult brain) tissues were indeed similar (- 1-2 x l0- 5 ) (18, 19). The 
relative initial frequencies of these ethylation products in DNA were - 55% (N7_ 
EtG), - 28% (06-EtG), and - 17% (N3_EtA), respectively. The same relative 
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FIG. 3. Separation of bases from brain DNA by radiochromatography on Sephadex G-IO, 
at 4 hr after ethylation in vivo by an i.p. pulse of 75 fig of [P4C]-ENU /g body wit. to IO-day-
old BDIX rats. Konradioactive N3-EtA, N'-EtG, and O"-EtG were added as "markers" (18, 
19). 
base ethylation frequencies were found after incubation of rat liver DNA with 
[l-14C]-ENU for I hr at 3rC in 25 mM potassium phosphate buffer, pH 7.2 (19). 
Therefore, the initial degree of purine base ethylation in DNA per se does not pro-
vide an explanation for the NS specificity of the carcinogenic effect. It was, how-
ever, of interest to find that 06-EtG is a major product of ethylation by ENU in 
vivo and in vitro. Among the different possible substitutions of purine bases in DNA, 
Q6-alkylguanine is particularly likely to cause miscoding and anomalous base-
pairing during subsequent DNA replication, and represents a mutagenic and thus 
potentially carcinogenic event (23, 34, 35). Formation of 06-alkylguanine in DNA 
after in vivo administration of alkylating N-nitroso carcinogens primarily of the 
"SN I-type" (36) has recently been reported by several authors (18, 19, 31, 37-40). 
The relative yield of 06-EtG obtained in the present analyses was ca. 4 times higher 
than the corresponding 06-methylguanine value reported for the less carcinogenic 
(41) methylating homologue of ENU, N-methyl-N-nitrosourea (MNU) (39). 
Furthermore, the same molar fractions of N7-EtGjG, Q6-EtGjG and N3-EtAjA 
were obtained in fetal DNA, when ENU was administered during temporary 
reduction of the rate of fetal DNA replication to ,..., I % of the control value by 
hydroxyurea (500 pgjg body weight, injected I hr prior to the ENU pulse) (19). 
Correspondingly, significant differences in the degree of base ethylation were 
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neither observed in fetal or 10-day-old versus adult rat tissues nor in liver DNA, 
when the ENU pulse was placed into the "prereplicative phase" (at II hr) versus 
the phase of maximum DNA replication (at 24 hr) after partial hepatectomy (19). 
With respect to 06_G, this indicates that ethylation is not restricted to a situation 
where this position is not "protected" by hydrogen bonding (i.e., replicating DNA). 
In the present analyses of DNA ethylated by ENU in vivo or in vitro, only 20-
30% of the total HC-activity in the Sephadex G-IO radiochromatograms was due 
to ethylated purine bases (18, 19). Most of the remaining HC-activity eluted im-
mediately after the void volume (Fig. 3). Although this "early peak" (19) includes 
ethylated pyrimidine nucleotides (not investigated in this study), there is evidence 
suggesting that its major component are phosphotriesters formed by reaction of 
the ENU-derived ethyl cation with the phospho diester groups of DNA (19, 42-45). 
These appear to be relatively stable in DNA (40), and could cause alterations of 
conformation (46) and molecular interactions (47), possibly resulting in a reduced 
susceptibility of DNA to enzymatic hydrolysis (43). Phosphotriester formation in 
DNA has recently been proposed to be a potentially important molecular event in 
the process of carcinogenesis by alkylating agents (23, 45). 
2. Elimination rates of ethylated purine bases from the DNA of" high-risk" and" low-risk" 
rat tissues 
Since cellular repair processes for structurally modified DNA involve the re-
moval of altered bases from DNA (11-20), the tissue-specific carcinogenic effect of 
ENU could possibly result from tissue differences in the elimination rates of poten-
tially mutagenic ethylated bases from DNA. Measurements were, therefore, per-
formed over a period of 240 hr following the ENU pulse of the elimination rates 
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FIG. 4. Kinetics of the elimination of 06-EtG from the DNA of different tissues of 10-day-
old BDIX rats in vivo. Molar fraction of06-EtG/G in DNA of brain, liver, and other pooled tis-
sues (intestine, kidney, lung, muscle, spleen), as a function of time after an i.p. pulse of 75 pg 
of [J-l'C]-ENU/g body wt. For comparison: 06-EtG/G in the DNA of pooled tissues (isolated 
at 4 hr after an [1_uC]-ENU pulse in vivo, and dissolved in 25 mM potassium phosphate buffer, 
0.02% sodium azide, pH 7.2), incubated in t'itro at 37°C for 240 hr (18). 0 in vitro; • brain; 
X liver; t::. other tissues pooled. 
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FIG. 5. Brain-liver ratio for the molar contents in DNA of 06-EtG/G (.) and N'-EtG/G (0), 
respectively, and for the "early peak" specific HC-activity (expressed as dpm/mg of input DNA; 
compare Fig. 3) in the Sephadex G-IO radiochromatograms (Ll. Goth and Rajewsky, unpublish-
ed results), as a function of time after an i.p. pulse of 75 pg of [J-l'C]-ENU/g body wt. to 10-
day-old BDIX rats. Initial values at I hr after the carcinogen pulse, normalized to 1.0 (18, 
19). 
of N7-EtG, 06-EtG and N3-EtA from the DNA of different tissues of lO-day-old 
BDIX rats (17-19). The data obtained by these analyses revealed a remarkable 
difference between brain on the one hand, and liver and a number of other "low-
risk" tissues on the other. 06-EtG disappeared from brain DNA very much more 
slowly (t1/2 - 229 hr) than from liver DNA (t1/2 - 36 hr) or from the DNA of several 
other (pooled) tissues (kidney, lung, spleen, intestine, muscle; t1/ 2 -54 hr); and 
also more slowly than N7-EtG and N3-EtA whose respective half lives were similar 
in brain and liver DNA (Figs. 4 and 5, Table 1). Equally similar for brain and 
liver DNA were the halflives (/1/2 -115 hr and 99 hr, respectively) of the integral 
He-activity of the "early peaks" (mainly attributed to ethylphosphotriesters) (19, 
23, 45) in the Sephadex G-IO radio chromatograms (Fig. 5). Incubation for 240 hr 
in vitro of DNA previously ethylated by ENU in vivo, showed complete stability of 
Q6-EtG in DNA, while the halflives of N7-EtG and N3-EtA in DNA were 11/ 2 ", 225 
hr and 11/ 2 -33 hr, respectively (Table 1) (19). In view of the mutagenic potential 
of guanine-06 alkylation (22, 23, 34, 35), it appears conceivable that the selective 
persistence of 06-EtG in brain DNA, together with the high rate of DNA replication 
and cell division at this developmental stage of the rat NS, could increase the 
probability of malignant transformation. This, in turn, might provide an explana-
tion for the NS specificity of the carcinogenic effect of ENU. In the same context, 
it remains to be investigated whether, and in which way, the presence in DNA of 
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TABLE I. Half Lives (hr) of Ethylated Purine Bases in the DNA of Different Tissues, after an Intraperito-
neal Pulse of [peC]-ENU to 10-day-old BDIX Rats (18-20) 
Brain 
Liver 
Tissue 
Other tissues (pooled) 
DNA (ethylated in vivo) 
In vivo lin vitro 
In vivo 
In vivo 
In vivo 
In vitro·) 
-------
N3-EtA 
160 ) 
12&) 
Not measured 
330 
----
----
N7-EtG 06-EtG 
- -----~- -
8gb) 22gb ) 
64b ) 360 ) 
60d ) 54d ) 
2250 Stablefl 
&) Observation period: 1-25 hr after [peC]-ENU pulse. b) Observation period: 25-240 hr after [peC]-
ENU pulse. 0) Observation period: 25-114 hr after [J-IeC]-ENU pulse. d) Based on measurements 
at 1,4, and 240 hr after [peC]-ENU pulse. 0) 25 mM potassium phosphate buffer (0.02% sodium azide); 
pH 7.2; 37°C. 0 Observation period: 1-240 hr after the beginning of incubation. 
alkylated purines such as 06-EtG could also impair interactions of DNA with re-
gulatory proteins involved in the control of gene expression (48-50). 
The observed differences in the elimination rates from DNA of 06-EtG are 
unlikely to result from differential dilution of this ethylation product in DNA 
due to different rates of DNA replication and cell division in the respective tissues. 
If this were the case, the elimination rates, e.g., of N7-EtG from brain versus liver 
DNA, should differ by a factor similar to that found for the half lives of 06-EtG, 
unless large differences existed in these tissues with regard to intranuclear condi-
tions for the hydrolysis of glycosidic linkages leading to release of N7-EtG from 
DNA. Rather, the data strongly argue for the existence of a specific enzymatic 
mechanism for the recognition and elimination of 06-alkylguanine from DNA, 
which is either lacking or substantially less effective in rat brain (18, 19). Such a 
mechanism could basically operate according to the scheme of excision repair 
(11), involving specific enzymes for recognition and elimination of modified bases, 
and subsequent repair of the resulting apurinic sites. A mammalian enzyme 
selectively releasing 06-alkylguanine from DNA has thus far not been identified. 
However, recent data from several laboratories (51-56) suggest that this may soon 
be the case. 
Selective persistence in the DNA of rat brain has recently also been demon-
strated for 06-methylguanine (06-MeG), when the predominantly NS-specific car-
cinogen MNU was applied over a period of 35 days (57, 58). Since kidney tumors 
are known to develop occasionally after single high doses of MNU (59), it is of 
interest that a low degree of accumulation of 06-MeG was also found in kidney 
DNA. Extending these analyses to the dialkylnitrosamines, it was further shown 
(60, 61) that after a single high dose of 20 Pg of dimethylnitrosamine (DMN)/g to 
adult rats (which induces tumors of the kidney but not of the liver) (62), 06-MeG 
is much more slowly eliminated from kidney DNA, than after a low (not kidney-
tumorigenic) dose (2.5 pg of DMN/g) or from liver DNA after either dose. This 
suggests that the enzyme system responsible for the elimination of 06-alkylguanine 
from DNA, either has only a limited capacity or can be inhibited by high doses 
of the alkylating carcinogen. 
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Neoplastic Transformation of Fetal Rat Brain Cells in Culture after Exposure ~o ENU in Vivo 
The above data have been obtained on whole tissues; i.e., they do not provide 
information on the differentiative and proliferative properties of the particular 
(precursor?) brain cells undergoing neoplastic transformation after exposure to 
ENU. Furthermore, the interval between primary carcinogen-cell interaction and 
the onset of clonal tumor growth remains a largely unclarified phase in the process 
of carcinogenesis. Yet this period may involve a characteristic sequence of pheno-
typic and functional alterations of the presumptive cancer cells. Investigation of 
these problems in vivo is hampered by the complex composition of intact tissues, 
together with the fact that apparently only a minor fraction of their constituent 
cells undergo the changes ultimately resulting in expression of a "malignant pheno-
type." On the other hand, cultured cells as target populations for oncogenic agents 
(3, 63) have obvious limitations as substitutes for the highly controlled cell systems 
in vivo with their distinct subcompartments of proliferating and differentiating 
cells (27). Furthermore, by the capacity for "unlimited" proliferation acquired by 
established cell cultures, part of the process of carcinogenesis might be anticipated. 
We have recently shown (27) that these limitations of in vitro systems may in 
part be circumvented if a tissue-specific carcinogen (ENU) is administered in vivo, 
prior to transfer of the respective target cells (fetal BDIX-rat brain cells; FBC) into 
long-term cell culture. This "in vivo-in vitro system" (Fig. 6) combines several favor-
able features: (1) The target cells are exposed to the carcinogen under physiological 
conditions in vivo. (2) The sequence of events subsequently monitored in vitro, occurs 
in a cell population derived from the very cell system giving rise to neuroectodermal 
tumors in vivo after an ENU pulse at the perinatal age. (3) Fetal rat cells appear 
to undergo "spontaneous" neoplastic transformation in culture less frequently 
than embryonic cells from other rodent species (64). (4) With the aid of different 
markers (65-69), the resulting neoplastic cell lines can be analyzed for phenotypic 
expression of NS-specific properties. (5) Under standardized conditions, the system 
may be applicable to assay the transformation frequency of preselected subpopula-
tions of FBC. 
Single cell suspensions of FBC, transferred to long-term monolayer cell culture 
at 20-90 hr after a pulse of 75 pg of ENU/g body weight administered on the 18th 
day of gestation, became tumorigenic after - 200 days (as assayed by reimplanta-
tion into baby BDIX rats) (27, 70). This time interval is similar to the average peri-
od of time (- 195 days) until death with neuroectodermal tumors, in the offspring 
of BDIX rats injected with the same dose of ENU at the same stage of gestation 
(19, 27). Acquisition of tumorigenicity in culture was preceded by a characteristic 
sequence of phenotypic alterations, termed "Stages I-IV" (Figs. 6 and 7; Table 
2). During early primary culture (Stage I), both ENU and untreated control 
cultures exhibited stationary glia-like cells on a growing layer of flat, epithelioid 
(possibly glial precursors) (27, 70) and few fibroblastoid cells. Stage II (- lOth-
40th day) was characterized by a constant proportion of glia-like cells in the ENU 
cultures, and their gradual disappearance in the controls. During Stage III (,.., 
40th-100th day), slowly-proliferating glia-like cells in the ENU cultures formed 
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FIG. 6. Diagrammatic representation of the in vivo-in titro system for neoplastic transformation 
of fetal BDIX-rat brain cells by ENU. CNS, central nervous system; PNS, peripheral nervous 
system (27). 
-+ FIG. 7 (a-f). Phenotypic alterations of FBC (18th day of gestation) during neoplastic trans-
formation in culture, after a transplacental pulse of 75 pg of ENUjg body wt. in lIivo (phase 
contrast micrographs) (27). (a) Secondary FEC (untreated control; 19th day in culture). 
GJia-like cells on dense layer of fiat, epithelioid and few fibroblast-like cells. (b) Later ap-
pearance of FBC culture shown in (a); 3rd culture passage. Glia-like cells have disappeared, 
but the flat epithelioid cell layer persists for sometimes up to \0 months (!). (c) Primary 
culture (8th day) of FBC exposed to ENU in vivo. Multiple glia-like cells on dense layer of 
flat, epithelioid and few fibroblast-like cells (Stage II, see Fig. 6). (d) FBC exposed to ENU 
in vivo (4th culture passage). Multifocal proliferation of glia-like cells with long cytoplasmic 
processes. Piled-up foci (Stage Ill, see Fig. 6). (e) Glia-like cells shown in (d), after separa-
tion from underlying cell layer and further subculture (advanced Stage III, see Fig. 6). 
Strong resemblance to astrocytes ; note apparent intercellular communication. (f) FBC ex-
posed to ENU in vivo (7th culture passage). Rapid, disordered proliferation of "morphological-
Iy transformed" cells (shorter and fewer cytoplasmic processes per cell; Stage IV, see Fig. 6). 
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TABLE 2. In Vivo-in Vitro System for Neoplastic Transformation of Fetal (18th Day of Gestation) BDIX-
rat Brain Cells in Culture, after Exposure to ENU in Vivo 
Days 
Mean (±S.E.) 98 (±20) 
Passage 
number 
4 (±0.7) 
Days 
138 (± 19) 
Passage 
number 
6 (±2) 
Days 
199 (±28) 
Passage 
number 
12 (±2) 
Average time intervals between transplacental ENU pulse (75 pg of ENU /g body wt.) and first observation 
of " morphological transformation" (Iy), ability to form colonies in semi-solid agar medium (tA), and 
tumorigenicity upon reimplantation into isogeneic hosts (IT)' Mean values (±S.E.) for 7 independent sets 
of experiments. Cell suspensions from 6-10 pooled fetal brains per experiment (6; 10 separate cultures; 1-
2 X lOe viable cells per 100 mm Falcon plastic dish or 250 ml plastic flask; Eagle-Dulbecco medium, 10% 
inactivated bovine serum; gassed with 5% CO2 in humidified air) (27). a) Time interval between ENU 
pulse in vivo and first observation of morphological transformation. b) Time interval between ENU pulse 
in vivo and first observation of ability to form colonies in semisolid agar medium. Initial cloning efficiency 
of 10' viable cells seeded into 30ml of 0.15% agar medium, 0.9± 0.3% (S.E.). 0) Time interval between 
ENU pulse in vivo and first observation of tumorigenicity. The time interval from subcutaneous reimplanta-
tion of 108 cells into baby BDIX rats, until the first tumors became palpable, was 48± 13 days (S.E.). 
However, much longer latency intervals (~IO months) were occasionally recorded. 
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FIG. 8. Growth curves for the (neoplastic) neurogenic ce1lline BT5C durin~ culture passages 
8 (Stage IV ; see Fig. 6) and 25 (Stage V ; Fig. 6), respectively. Population doubling times 
(In) and maximum cell densities were tn =43 hr (8 X 10' cells/em') during the 8th passage, and 
tn =22 hr (30x 10' cells/em') during the 25th passage, respectively. A curve for secondary 
FBC (19th day of gestation; untreated control) is given for comparison (27). /). BT5C (25th 
passage) ; • BT5C (8th passage) ; 0 fetal brain cells. 
"piled-up" foci. These could be removed and cultured separately. Transition to 
Stage IV (ca. lOOth-200th day) was marked by proliferation of morphologically 
transformed cells, which formed colonies in semi-solid agar, and finally became 
tumorigenic (Stage V; see Fig. 8 for comparison of proliferation rates during 
Stages IV and V, and Table 2 for average time intervals between the different 
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stages). The solid tumors developed upon subcutaneous reimplantation of the 
resulting neoplastic neurogenic cell lines ("BT lines") (70) into baby BDIX rats, 
appeared histologically as neurinoma-, glioma-, or glioblastoma-like, and frequently 
pleiomorphic neoplasms. Although exhibiting a more atypical cellular morphology, 
these tumors resembled the different types of neuroectodermal rat neoplasms in-
duced by ENU in vivo. Like several neurogenic cell culture lines ("V lines") (70) 
derived from ENU-induced, neuroectodermal BDIX-rat tumors (27, 70-73), the 
BT lines contained multipolar, glia-like cells, but also flatter cells with shorter and 
fewer cytoplasmic processes, and occasionally giant cells. The pluriclonal "paren-
tal" BT and V lines exhibited different degrees of aneuploidy, and contained multiple 
subpopulations of cells, as reflected by plurimodal DNA distributions recorded by 
pulse-cytophotometry (Fig. 9) (70, 74, 75). All parental lines and their (cloned) 
sublines (total number> 30) expressed, to a varying extent, the NS-specific "mark-
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FIG. 9. Pulse-cytophotometric DNA distributions of the original ("parental") neoplastic, 
neurogenic ."V line" (27, 70) NVIC (125th culture passage; above), and of2 NVIC-derived, 
c~oned sublmes (NVICb, 0 ; and NVICc, .) in their 43rd and 40th culture passage, respec-
tI~ely (below). Data for 5-10 X 10' ethidium bromide-stained, log-phase cells, respectively. Eup-
lOid log-phase BDIX-rat embryo cells had a relative modal G.-DNA value corresponding to 
channel No. 16. Pulse-cytophotometer ICP I I (PHYWE AG r-~tt' G ) N t 
. . . . ' uu mgen, ermany. 0 e 
t?e ummodal DNA dlstnbutlOns of the cloned sublines, as opposed to the plurimodal distribu-
tIon of the parental line (70, 14, 75). 
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er" protein S-lOO, which is virtually absent in FBC (65, 70). There was no indica-
tion of more than borderline neurotransmitter activity (acetylcholinesterase, choline 
acetyltransferase, L-glutamate decarboxylase I) (67, 70), nor has electrical mem-
brane excitability thus far been detected (76). Serological analyses in the Ouchter-
lony test, of selected BT and V lines gave no evidence for the presence of group-
specific(gs) interspecies oncornaviral antigens (by courtesy of Prof. W. Schafer 
of this institute) (27, 70, 77). 
To this date, this "in vivo-in vitro system" has not permitted subpopulations of 
probable "high-risk" FBC to be defined with certainty. Yet, the glia-like mor-
phology of the particular cells that underwent "morphological transformation" 
and the demonstration, in the resulting neoplastic cell lines, of the predominantly 
glial S-lOO marker protein (with the lack of evidence for expression of neuronal 
properties) (27, 70, 76), make glia cells, or rather their (proliferative) precursors 
potential candidates (18,27, 70). The latter would be in accordance with the 
assumption that the risk of malignant transformation may vary with the stage of 
the target cells in their differentiative pathway at the time of interaction with a 
carcinogen (9, 18, 19, 27). For example, the probability of a genetic "fixation" 
of carcinogen-induced modifications of DNA may depend on the number of 
rounds of DNA replication that target cells would still (be programmed to?) 
undergo, before reaching a terminally differentiated, nonproliferative state (with 
much reduced risk of neoplastic conversion). 
Neuroglia and neurons are, however, believed to have common neuroepithelial 
precursors (78); and immature cells of neuronal lineages were certainly not absent 
from the present FBC cultures initially. Therefore, neoplastic clones expressing both 
glial and/or neuronal properties might, in principle, have been expected to develop. 
However, during rat brain development, and on an overall scale, neurons precede 
the glial cell populations with respect to proliferation and differentiation (28). 
Hence, at the developmental stage chosen for the ENU pulse (18th day of gestation), 
the precursor compartments may predominantly contain glial precursors. This, in 
turn, might explain the prevalence of neoplastic cells with phenotypic traits of glial 
cells. It may, however, be noted, that some neoplastic cell lines expressing neuron-
like properties have recently been derived from neuroectodermal BDIX-rat tumors 
induced by application of ENU on the 15th day of gestation (73). 
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